Figure 2From: Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis Cumulative probability corticosteroid discontinuation in different TCZ regimens (Q2W vs. Q4W) between patients with Q4W and Q2W. Back to article page